Management of vaginal bleeding irregularities induced by progestin-only contraceptives

Human Reproduction

Volumn 15, Issue SUPPL. 3, 2000, Pages 24-29

  D'Arcangues, C ^a  

^a WORLD HEALTH ORGANIZATION   (Switzerland)

Author keywords

Contraception; Progestin; Vaginal bleeding

Indexed keywords

ESTRONE SULFATE; ETHINYLESTRADIOL; ETONOGESTREL; GESTAGEN; IBUPROFEN; LEVONORGESTREL; MEDROXYPROGESTERONE ACETATE; NORETHISTERONE;

ATTITUDE; CLINICAL TRIAL; CONFERENCE PAPER; HEALTH CARE MANAGEMENT; HORMONAL CONTRACEPTION; HUMAN; MENSTRUATION; MONOTHERAPY; TREATMENT FAILURE; TREATMENT OUTCOME; VAGINA BLEEDING;

EID: 0033824266     PISSN: 02681161     EISSN: None     Source Type: Journal    
DOI: 10.1093/humrep/15.suppl_3.24     Document Type: Conference Paper

References (25)

1. An integrated analysis of vaginal bleeding patterns in clinical trials of Implanon®
2. Hormonal treatment for bleeding irregularities in Norplant implant users
3. Long-interval treatment regimen with a desogestrel-containing oral contraceptive
4. Dysfunctional uterine bleeding induced by exogenous hormones
5. Preferred frequency and characteristics of menstrual bleeding in relation to reproductive status, oral contraceptive use, and hormone replacement therapy use
6. Clinical assessment of treatments for prolonged bleeding in users of Norplant implants
7. A survey of different approaches to management of menstrual disturbances in women using injectable contraceptives
8. Norplant consensus statement and background review
9. Attitudes to current oral contraceptive use and future developments: The women's perspective
10. Young women's attitudes toward injectable and implantable contraceptives
11. Postponement of withdrawal bleeding in women using low-dose combined oral contraceptives
12. Endometrial morphology and peripheral steroid levels in women with and without intermenstrual bleeding during contraception with the 300 μg norethisterone (NET) minipill
13. Effect of pretreatment counselling on discontinuation rates in Chinese women given depo-medroxyprogesterone acetate for contraception
14. Acceptability of an oral contraceptive that reduces the frequency of menstruation: The tri-cycle pill regimen
15. Effectiveness of Cyclofem in the treatment of depot medroxyprogesterone acetate-induced amenorrhea
16. Menstrual bleeding patterns in Chinese women using the Norplant subdermal implant
17. 'Once-a-month' combined injectable contraceptives
18. Treatment of bleeding problems associated with progestin-only contraceptives: Survey results
19. Women's attitudes to withdrawal bleeding and their knowledge and beliefs about the oral contraceptive pill
20. Detailed analysis of menstrual bleeding patterns after postmenstrual and postabortal insertion of a copper IUD or a levonorgestrel-releasing intrauterine system
21. Oestrogen treatment for increased bleeding in Norplant users: Preliminary results
22. A multicentred Phase III comparative clinical trial of depot-medroxyprogesterone acetate given three-monthly at doses of 100mg or 150mg: II. The comparison of bleeding patterns
23. Clinical evaluation of the therapeutic effectiveness of ethinyl oestradiol and oestrone sulphate on prolonged bleeding in women using depot medroxyprogesterone acetate for contraception